V C Nannapaneni 's Insider Trades & SAST Disclosures
V C Nannapaneni 's most recent trade in Natco Pharma Ltd. was a Acquisition of 5,440,045 Equity Shares done . Disclosure was reported to the exchange on June 28, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
V C Nannapaneni 's has made SAST transactions in Natco Pharma Ltd. recently where a Acquisition of 5,440,045 shares done . Disclosure was reported to the exchange on June 28, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | V C Nannapaneni & Others | Promoter | Acquisition | 19 Jul 2023 | 5,440,045 | 28,045,905 (15.66%) | 3.04% | - | 26 Jun 2023 26 Jun 2023 |
SAST (29(2)) | - | Off Market / Inter se transfer | |
| Natco Pharma | V C Nannapaneni & Others | Promoter | Disposal | 19 Jul 2023 | 5,440,045 | - | 3.04% | - | 26 Jun 2023 26 Jun 2023 |
SAST (29(2)) | - | Off Market / Inter se transfer | |
| Natco Pharma | V C NANNAPANENI | Promoter | Acquisition | 28 Jun 2023 | 5,440,045 | 28,045,905 (15.66%) | 2.98% | 0 | 0 | 26 Jun 2023 27 Jun 2023 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Natco Pharma | Venkaiah Chowdary Nannapaneni HUF | Promoter | Disposal | 28 Jun 2023 | 5,440,045 | 0 (0%) | 2.98% | 0 | 0 | 26 Jun 2023 27 Jun 2023 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Natco Pharma | V C Nannapaneni | Promoter | Acquisition | 22 Dec 2022 | 9,050 | 22,605,860 (12.38%) | - | - | 19 Dec 2022 19 Dec 2022 |
SAST (29(2)) | - | Market | |
| Natco Pharma | V C NANNAPANENI | Promoter | Acquisition | 20 Dec 2022 | 9,050 | 22,605,860 (12.38%) | 0.00% | 550.8 | 4,984,761 | 19 Dec 2022 19 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Natco Pharma | V C Nannapaneni | Promoter | Acquisition | 06 Dec 2022 | 8,880 | 22,596,810 (12.38%) | - | - | 30 Nov 2022 30 Nov 2022 |
SAST (29(2)) | - | Market | |
| Natco Pharma | V C NANNAPANENI | Promoter | Acquisition | 01 Dec 2022 | 8,880 | 22,596,810 (12.38%) | 0.00% | 562.2 | 4,991,932 | 30 Nov 2022 30 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.